Diseases of the central nervous system are found in patients with severe
hyperhomocysteinemia (HHcy). Epidemiological studies show a positive, dose-dependent …

Homocysteine (Hcy) is a sulfur-containing non-proteinogenic amino acid formed during the
metabolism of the essential amino acid methionine. Hcy is considered a risk factor for …

Homocysteine is produced physiologically in all cells, and is present in plasma of healthy
individuals (plasma [HCy]: 3–10 μM). While rare genetic mutations (CBS, MTHFR) cause …

Introduction Among numerous risk factors, homocysteine (Hcy) has been linked to cerebral
infarction; however, results have been inconsistent. This review aimed to conduct a meta …

Homocysteine, a sulphur-containing amino acid derived from methionine, has been
presented as an independent risk factor for cardiovascular disorders, including …

BACKGROUND Hyperhomocysteinemia and the metabolic syndrome are established
cardiovascular risk factors and are frequently associated with hypertension. The relationship …

Mild hyperhomocysteinemia has been suggested as a new, independent risk factor for
cardiovascular disease. This fact has produced a new, increased interest in the study of …

Objectives: Review the indications for obtaining a homocysteine level. Summarize who
should receive treatment for hyperhomocysteinemia. Identify patients who would have …

Oxidative stress due to the production of intracellular and extracellular reactive oxygen
species may be a major player in the pathogenesis of cardiovascular and other diseases …

An association between arteriosclerosis and homocysteine (Hcy) was first demonstrated in
1969. Hcy is a sulfur containing amino acid derived from the essential amino acid …